1. BY1023/SK&F96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions;Kromer;J Pharmacol Exp Ther,1990
2. Single intravenous administration of BY1023/SK&F96022-inhibition of pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man;Simon;Aliment Pharmacol Ther,1990
3. Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K+-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers;Simon;Z Gastroenterol,1990
4. Effect of repeated oral administration of BY1023/SK&F96022-a new substituted benzimidazole derivative-on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man;Simon;Aliment Pharmacol Ther,1990
5. 24h intragastric pH following oral intake of pantoprazole and omeprazole. In: Management of Acid-Related Diseases: Focus on Pantoprazole;Hartmann;Hell J Gastroenterol,1992